Skip to main content
Back
VTR logo

Ventas, Inc.

Data quality: 100%
VTR
NYSE Real Estate REIT - Healthcare Facilities
$81.85
▼ $0.65 (-0.79%)
Mkt Cap: 38.88B
Day Range
$81.76 $84.03
52-Week Range
$60.15 $88.37
Volume
1,942,535
50D / 200D Avg
$82.26 / $73.42
Prev Close
$82.50

Price History

Financial Trends

Peer Comparison

vs Real Estate sector median (361 peers)

Metric Stock Sector Median
P/E 154.7 11.2
P/B 3.1 0.8
ROE % 2.2 6.1
Net Margin % 4.3 19.9
Rev Growth 5Y % 11.1 6.9
D/E 1.1 0.9

Analyst Price Target

Hold
$90.33 +10.4%
Low: $85.00 High: $100.00
Forward P/E
107.6
Forward EPS
$0.76
EPS Growth (est.)
+0.0%
Est. Revenue
6.5 B

Earnings Estimates

Period EPS Est. Revenue Est. Analysts
FY2029 $1.84
$1.77 – $1.92
 7.8 B 2
FY2028 $1.33
$1.17 – $1.40
 7.5 B 4
FY2027 $1.13
$1.09 – $1.18
 7.1 B 6

Key Takeaways

Revenue grew 11.11% annually over 5 years — strong growth
Earnings grew 209.76% over the past year
ROE of 2.16% is below average
Generating 1.32B in free cash flow
P/E of 154.65 — premium valuation
PEG of 0.80 suggests growth is underpriced

Growth

Revenue Growth (5Y)
11.11%
Revenue (1Y)18.47%
Earnings (1Y)209.76%
FCF Growth (3Y)18.65%

Quality

Return on Equity
2.16%
ROIC2.41%
Net Margin4.31%
Op. Margin14.17%

Safety

Debt / Equity
1.06
Current Ratio0.96
Interest Coverage1.35

Valuation

P/E Ratio
154.65
P/B Ratio3.10
EV/EBITDA62.11
Dividend Yield0.02%

All Fundamental Metrics

Growth
Revenue Growth (1Y) 18.47% Revenue Growth (3Y) 13.89%
Earnings Growth (1Y) 209.76% Earnings Growth (3Y) N/A
Revenue Growth (5Y) 11.11% Earnings Growth (5Y) 50.49%
Profitability
Revenue (TTM) 5.83B Net Income (TTM) 251.38M
ROE 2.16% ROA 0.91%
Gross Margin -5.90% Operating Margin 14.17%
Net Margin 4.31% Free Cash Flow (TTM) 1.32B
ROIC 2.41% FCF Growth (3Y) 18.65%
Safety
Debt / Equity 1.06 Current Ratio 0.96
Interest Coverage 1.35 Dividend Yield 0.02%
Valuation
P/E Ratio 154.65 P/B Ratio 3.10
P/S Ratio 6.66 PEG Ratio 0.80
EV/EBITDA 62.11 Dividend Yield 0.02%
Market Cap 38.88B Enterprise Value 51.35B

Income Statement

Annual, most recent first

Income statement data, annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue 5.83B 4.92B 4.50B 4.13B 3.83B
Net Income 251.38M 81.15M -40.97M -47.45M 49.01M
EPS (Diluted) 0.54 0.19 -0.10 -0.13 0.13
Gross Profit -344.22M 2.10B 1.94B 1.85B 1.74B
Operating Income 826.81M 681.23M 415.51M 483.85M 421.43M

Balance Sheet

Annual, most recent first

Balance sheet data, annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 27.59B 26.19B 24.73B 24.16B 24.72B
Total Liabilities 15.01B 15.36B 15.18B 13.94B 13.77B
Shareholders' Equity 12.53B 10.77B 9.49B 10.15B 10.85B
Total Debt 13.22B 13.74B 13.69B 12.49B 12.22B
Cash & Equivalents 741.07M 897.85M 508.79M 122.56M 149.73M
Current Assets 1.33B 1.35B 868.20M 964.59M 951.02M
Current Liabilities 1.39B 1.30B 1.18B 1.58B 1.54B

Strategy Scores

This stock passed the criteria for 1 strategy

Score = fit strength (0–100)
Rank = position among all matches
Custom Cash Flow Compounder
#551 of 1024
43

Recent Activity

Entered Cash Flow Compounder
Mar 24, 2026